Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines

Oncology Letters

Volumn 4, Issue 6, 2012, Pages 1264-1268

  Ling, Gui Qin ^a   Chen, Dong Bo ^a   Wang, Bao Qing ^a   Zhang, Lan Sheng ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Embryonic stem cell marker; Nanog; Oct3 4; Sox 2

Indexed keywords

MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84867243788     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.916     Document Type: Article

References (44)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Gonzalez-Angulo AM, Morales-Vasquez F and Hortobagyi GN: Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 608: 1-22, 2007.
3. Ben-Porath I, Thomson MW, Carey VJ, et al: An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40: 499-507, 2008.
4. Pesce M and Schöler HR: Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 19: 271-278, 2001.
5. Rodda DJ, Chew JL, Lim LH, et al: Transcriptional regulation of nanog by OCT4 and SOX2. J Biol Chem 280: 24731-24737, 2005.
6. Ezeh UI, Turek PJ, Reijo RA and Clark AT: Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104: 2255-2265, 2005.
7. Hart AH, Hartley L, Parker K, et al: The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 104: 2092-2098, 2005.
8. Hoei-Hansen CE, Almstrup K, Nielsen JE, et al: Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology 47: 48-56, 2005.
9. Santagata S, Hornick JL and Ligon KL: Comparative analysis of germ cell transcription factors in CNS germinoma reveals diagnostic utility of NANOG. Am J Surg Pathol 30: 1613-1618, 2006.
10. Jones TD, Ulbright TM, Eble JN, Baldridge LA and Cheng L: OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 28: 935-940, 2004.
11. Cheng L: Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer 101: 2006-2010, 2004.
12. Hochedlinger K, Yamada Y, Beard C and Jaenisch R: Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121: 465-477, 2005.
13. Zhang J, Wang X, Chen B, et al: Expression of Nanog gene promotes NIH3T3 cell proliferation. Biochem Biophys Res Commun 338: 1098-1102, 2005.
14. Jeter CR, Badeaux M, Choy G, et al: Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27: 993-1005, 2009.
15. Sanada Y, Yoshida K, Ohara M, Oeda M, Konishi K and Tsutani Y: Histopathologic evaluation of stepwise progression of pancreatic carcinoma with immunohistochemical analysis of gastric epithelial transcription factor SOX2: comparison of expression patterns between invasive components and cancerous or nonneoplastic intraductal components. Pancreas 32: 164-170, 2006.
16. Li XL, Eishi Y, Bai YQ, et al: Expression of the SRY-related HMG box protein SOX2 in human gastric carcinoma. Int J Oncol 24: 257-263, 2004.
17. Bass AJ, Watanabe H, Mermel CH, et al: SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 41: 1238-1242, 2009.
18. Lengerke C, Fehm T, Kurth R, et al: Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer 11: 42, 2011.
19. Rodriguez-Pinilla SM, Sarrio D, Moreno-Bueno G, et al: Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer. Mod Pathol 20: 474-481, 2007.
20. Chen Y, Shi L, Zhang L, et al: The molecular mechanism governing the oncogenic potential of SOX2 in breast cancer. J Biol Chem 283: 17969-17978, 2008.
21. Lee J, Kim HK, Rho JY, Han YM and Kim J: The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem 281: 33554-33565, 2006.
22. Tai MH, Chang CC, Kiupel M, Webster JD, Olson LK and Trosko JE: Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis 26: 495-502, 2005.
23. Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768, 2008.
24. Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL and Wu CL: Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res 68: 6281-6291, 2008.
25. Matin MM, Walsh JR, Gokhale PJ, et al: Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 22: 659-668, 2004.
26. Cauffman G, Liebaers I, Van Steirteghem A and Van de Velde H: POU5F1 isoforms show different expression patterns in human embryonic stem cells and preimplantation embryos. Stem Cells 24: 2685-2691, 2006.
27. Gidekel S, Pizov G, Bergman Y and Pikarsky E: Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4: 361-370, 2003.
28. Looijenga LH, Stoop H, de Leeuw HP, et al: POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63: 2244-2250, 2003.
29. Atlasi Y, Mowla SJ, Ziaee SA and Bahrami AR: OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer. Int J Cancer 120: 1598-1602, 2007.
30. Seigel GM, Hackam AS, Ganguly A, Mandell LM and Gonzalez-Fernandez F: Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis 13: 823-832, 2007.
31. Chiou SH, Yu CC, Huang CY, et al: Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 14: 4085-4095, 2008.
32. Chen YC, Hsu HS, Chen YW, et al: Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS One 3: e2637, 2008.
33. Okita K, Ichisaka T and Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317, 2007.
34. Park IH, Zhao R, West JA, et al: Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146, 2008.
35. Pan GJ, Chang ZY, Schöler HR and Pei D: Stem cell pluripotency and transcription factor Oct4. Cell Res 12: 321-329, 2002.
36. Darr H, Mayshar Y and Benvenisty N: Overexpression of NANOG in human ES cells enables feeder-free growth while inducing primitive ectoderm features. Development 133: 1193-1201, 2006.
37. Zaehres H, Lensch MW, Daheron L, Stewart SA, Itskovitz-Eldor J and Daley GQ: High-efficiency RNA interference in human embryonic stem cells. Stem Cells 23: 299-305, 2005.
38. Wang L, Park P and Lin CY: Characterization of stem cell attributes in human osteosarcoma cell lines. Cancer Biol Ther 8: 543-552, 2009.
39. Siu MK, Wong ES, Chan HY, Ngan HY, Chan KY and Cheung AN: Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome. Am J Pathol 173: 1165-1172, 2008.
40. Jordan CT, Guzman ML and Noble M: Cancer stem cells. N Engl J Med 355: 1253-1261, 2006.
41. Wang L, Park P, Zhang H, La Marca F and Lin CY: Prospective identification of tumorigenic osteosarcoma cancer stem cells in OS99-1 cells based on high aldehyde dehydrogenase activity. Int J Cancer 128: 294-303, 2011.
42. Wilbertz T, Wagner P, Petersen K, et al: SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod Pathol 24: 944-953, 2011.
43. Dong C, Wilhelm D and Koopman P: Sox genes and cancer. Cytogenet Genome Res 105: 442-447, 2004.
44. Santagata S, Ligon KL and Hornick JL: Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am J Surg Pathol 31: 836-845, 2007.